🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to estimate the safety and the efficacy of ant...
Status
Not Yet Recruiting
Location
State Institution Minsk Scientific and Practical Center for Surgery, Transplantology, and Dermatology
Start Date
2026-01-01
Trial ID
NCT07162571
Treatments Being Tested
This study examines the safety, tolerability and preliminary efficacy of an...
Status
Recruiting
Location
The First Affiliated Hospital of Nanchang University;
Start Date
2024-05-31
Trial ID
NCT06445803
Treatments Being Tested
Clinical Trial for the Efficacy and Safety of Sequential CD19 and CD22 CAR-...
Status
Completed
Location
The First Affiliated Hospital, College of Medicine, Zhejiang University
Start Date
2021-03-05
Trial ID
NCT04788472
Treatments Being Tested
This phase I trial tests the safety, side effects and best infusion dose of...
Status
Recruiting
Location
Nationwide Children's Hospital
Start Date
2022-06-30
Trial ID
NCT05418088
The primary purpose of this study is to determine safety, feasibility, and ...
Status
Recruiting
Location
Stanford University
Start Date
2024-05-13
Trial ID
NCT06408194
Treatments Being Tested
Chimeric antigen receptor T-cell (CAR-T) therapy has achieved remarkable ef...
Status
Active Not Recruiting
Location
The First Affiliated Hospital of Soochow University
Start Date
2020-01-19
Trial ID
NCT05470777
Treatments Being Tested
Evaluation the safety,tolerability, preliminary efficacy,and PK/PD of CD19-...
Status
Unknown
Location
Hematology Department of ShanXi Cancer Hospital
Start Date
2021-01-15
Trial ID
NCT04714593
Treatments Being Tested
The primary purpose of this study is to test whether CD22-CAR T cells can b...
Status
Completed
Location
Stanford Medical Center
Start Date
2020-01-10
Trial ID
NCT04088864
Treatments Being Tested
To assess the safety of administering allogenic, donor-derived CD19/CD22-CA...
Status
Active Not Recruiting
Location
Stanford Cancer Center
Start Date
2022-08-18
Trial ID
NCT05507827
This phase I trial studies the best dose and side effects of CD19/CD22 chim...
Status
Active Not Recruiting
Location
Lucile Packard Children's Hospital Stanford University
Start Date
2017-10-20
Trial ID
NCT03241940